International Patent: NUCLEIC ACID CONSTRUCT, VECTOR, AND APPROACH TO REDUCE HIGH MANNOSE OF RECOMBINANT PROTEIN

GENEVA, July 2 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. filed a patent application (CN2025/143838) for “NUCLEIC ACID CONSTRUCT, VECTOR, AND APPROACH TO REDUCE HIGH MANNOSE OF RECOMBINANT PROTEIN”. With publication no. WO/2026/130515, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/85

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....